XML 24 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-based Compensation
9 Months Ended
Aug. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
STOCK-BASED COMPENSATION

We have three types of stock-based compensation awards: restricted stock units (RSUs), stock options and company stock awarded as part of our long-term performance plan (LTPP). The following table sets forth the stock-based compensation expense recorded in selling, general and administrative (SG&A) expense (in millions):
 
Three months ended August 31,
 
Nine months ended August 31,
 
2018
 
2017
 
2018
 
2017
Stock-based compensation expense
$
5.5

 
$
4.0

 
$
21.6

 
$
18.4


Our 2018 annual grant of stock options and RSUs occurred in the second quarter, similar to the 2017 annual grant. The weighted-average grant-date fair value of an option granted in 2018 was $20.30 and in 2017 was $17.61 as calculated under a lattice pricing model. Substantially all of the options granted vest ratably over a three-year period or upon retirement. The fair values of option grants in the stated periods were computed using the following range of assumptions for our various stock compensation plans:
 
2018
 
2017
Risk-free interest rates
1.7 - 2.9%
 
0.9 - 2.4%
Dividend yield
2.0%
 
1.9%
Expected volatility
18.4%
 
18.7%
Expected lives (in years)
7.6
 
7.6

The following is a summary of our stock option activity for the nine months ended August 31, 2018 and 2017:
 
2018
 
2017
(shares in millions)
Number
of
Shares
 
Weighted-
Average
Exercise
Price
 
Number
of
Shares
 
Weighted-
Average
Exercise
Price
Outstanding at beginning of period
4.8

 
$
71.91

 
4.9

 
$
66.00

Granted
0.4

 
105.95

 
0.6

 
98.07

Exercised
(0.9
)
 
51.82

 
(0.6
)
 
49.50

Outstanding at end of the period
4.3

 
$
79.31

 
4.9

 
$
71.59

Exercisable at end of the period
3.4

 
$
73.52

 
3.9

 
$
65.12

As of August 31, 2018, the intrinsic value (the difference between the exercise price and the market price) for all options outstanding was $194.2 million and for options currently exercisable was $173.9 million. The total intrinsic value of all options exercised during the nine months ended August 31, 2018 and 2017 was $56.9 million and $26.9 million, respectively.
The following is a summary of our RSU activity for the nine months ended August 31, 2018 and 2017:
 
2018
 
2017
(shares in thousands)
Number
of
Shares
 
Weighted-
Average
Grant-Date
Fair Value
 
Number
of
Shares
 
Weighted-
Average
Grant-Date
Fair Value
Outstanding at beginning of period
267

 
$
86.47

 
267

 
$
80.08

Granted
201

 
101.17

 
130

 
94.63

Vested
(117
)
 
88.35

 
(118
)
 
80.62

Forfeited
(6
)
 
95.68

 
(12
)
 
90.65

Outstanding at end of period
345

 
$
94.21

 
267

 
$
86.49


The following is a summary of our LTPP activity for the nine months ended August 31, 2018 and 2017:
 
2018
 
2017
(shares in thousands)
Number
of
Shares
 
Weighted-
Average
Grant-Date
Fair Value
 
Number
of
Shares
 
Weighted-
Average
Grant-Date
Fair Value
Outstanding at beginning of period
220

 
$
84.31

 
201

 
$
78.10

Granted
86

 
101.90

 
78

 
89.96

Vested
(59
)
 
74.02

 
(43
)
 
69.04

Forfeited
(2
)
 
96.74

 

 

Outstanding at end of period
245

 
$
92.87

 
236

 
$
83.63